Early Detection of Adrenal Insufficiency: The Impact of Newborn Screening for Adrenoleukodystrophy

Jonanlis Ramirez Alcantara1,2, Natalie R Grant3, Swathi Sethuram1,2

  • 1Department of Pediatric Endocrinology, Massachusetts General Hospital, Boston, MA 02114, USA.

Insights

Newborn screening for adrenoleukodystrophy (ALD) significantly speeds up the diagnosis of adrenal insufficiency (AI) in boys. Early ALD detection via NBS allows for prompt treatment, improving health outcomes for affected children.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Adrenoleukodystrophy (ALD) affects males, carrying an 80% risk of life-threatening adrenal insufficiency (AI).
  • Newborn screening (NBS) for ALD is available in 29 states, but its clinical impact on AI diagnosis remains unquantified.

Purpose of the Study:

  • To determine if ALD newborn screening (NBS) implementation has reduced the time to adrenal insufficiency (AI) diagnosis in pediatric patients.
  • To assess the effect of NBS on the clinical management of AI in boys with ALD.

Main Methods:

  • Retrospective medical chart review of pediatric patients diagnosed with ALD.
  • Inclusion criteria: patients seen at a leukodystrophy clinic between May 2006 and January 2022.
  • Data extracted: ALD diagnosis, AI surveillance, diagnosis, and treatment timing in boys.

Main Results:

  • 31% of patients were diagnosed via NBS; 74% of boys had AI.
  • AI diagnosis was significantly earlier in NBS-diagnosed boys (median 6.7 months) compared to non-NBS diagnosed boys (median 6.05 years).
  • Earlier NBS diagnosis correlated with significant differences in ACTH and cortisol levels at glucocorticoid initiation.

Conclusions:

  • Implementing NBS for ALD facilitates earlier detection of AI in affected boys.
  • Earlier AI diagnosis through NBS enables prompt glucocorticoid supplementation, potentially improving patient outcomes.
Abstract